Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Physicial Activity and Cardiorespiratory Fitness as Modulators of He…

Barry A. Franklin

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Stopping GLP-1 Receptor Agonist/Dual Agonist Therapy: When and How S…

Alyssa Lampe Dominguez

Functional Hypothalamic Amenorrhea: Consequences Beyond the Menstrua…

Heart in Diabetes (HiD)

C. Shufelt

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

ESC 2024 Insights

M. Böttcher

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

AUA 2024 Insights: " GLP-1 Receptor Agonists and Men's Health"

Insights from AUA 2024 Annual Meeting

E. Pozzi

Peripheral Artery Disease: It Takes All of Us!

University of Louisville

N. L. Lohr

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

What Every GP Should Know About Heart Failure in 2024?

Canadian Collaborative Research Network

S. Poon

MI With No Obstructive Disease: Is That a Thing

FACET

H. Hashim

Guideline Recommended Therapy in Patients With Diabetic Kidney Disea…

Heart in Diabetes (HiD)

M. R. Weir

Cardiovascular Disease in the Very Old

Heart in Diabetes (HiD)

C. Ballantyne

Diabetes: Matters of the Heart

Scripps Health

M. Wilkinson

Autoantibodies & Diabetes Screening, and the Advances in Novel Thera…

NYU Langone

M. Natter